St. Franziskus Hospital Flensburg
- Address
- Waldstraße 17, 24939 Flensburg, Germany
St. Franziskus Hospital Flensburg - Hematologic Malignancies Research
St. Franziskus Hospital Flensburg is a clinical research facility specializing in the investigation of hematologic disorders, with particular expertise in myelodysplastic syndromes (MDS). The center focuses on developing innovative therapeutic approaches for patients with blood disorders, emphasizing treatment strategies for lower-risk disease populations who may benefit from novel agents.
- Myelodysplastic syndromes (MDS) management in very low-, low-, and intermediate-risk patient populations
- Anemia treatment optimization in transfusion-independent MDS patients
- Evaluation of erythroid maturation agents and erythropoiesis-stimulating therapies
The hospital's research program particularly emphasizes treatment-naive patient populations, investigating novel approaches for managing anemia in MDS patients who do not require red blood cell transfusions. Their clinical trial portfolio includes evaluation of luspatercept and other erythropoiesis-modulating agents, contributing to the development of targeted therapies that can improve hematologic improvement-erythroid (HI-E) responses in this challenging patient population.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in St. Franziskus Hospital Flensburg
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy of Luspatercept in Erythropoiesis-Stimulating Agent-Naive Lower-Risk Myelodysplastic Syndromes with Anemia and Transfusion Independence | Universitaet Leipzig | Phase II | Not Recruiting | Sep 2022 | — |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Cannabidiol | 1 | Unknown | 2023-11-08 | 2023-11-08 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.